Guangdong Kanghua Healthcare Co., Ltd. Class H (HK:3689)
:3689
Want to see HK:3689 full AI Analyst Report?
Top Page
Guangdong Kanghua Healthcare Co., Ltd. Class H
(3689)
Select Model
Select Model
Rating:71Outperform
Price Target:
HK$2.50
▲(45.35% Upside)
Action:Reiterated
Date:05/04/26
The score is driven primarily by an attractive valuation (very low P/E and high dividend yield) and an improving financial profile with manageable leverage. Offsetting factors are uneven revenue and profitability history plus free-cash-flow volatility, while technicals are only moderately supportive with mixed momentum indicators.
Positive Factors
Improving leverage
A lower debt-to-equity (~0.22 in 2025 vs ~0.30–0.35 prior) strengthens financial flexibility and reduces refinancing risk. This durable improvement supports capital allocation for operations, investment or dividends and lowers downside risk if revenue softens over the next several quarters.
Negative Factors
Revenue inconsistency
Uneven top-line growth—volatile across 2020–2025 with a ~3.9% decline in 2025—suggests demand sensitivity or exposure to fluctuating volumes. Persistent revenue variability complicates forecasting, limits scale benefits, and raises execution risk for long-term margin expansion.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving leverage
A lower debt-to-equity (~0.22 in 2025 vs ~0.30–0.35 prior) strengthens financial flexibility and reduces refinancing risk. This durable improvement supports capital allocation for operations, investment or dividends and lowers downside risk if revenue softens over the next several quarters.
Read all positive factors
Guangdong Kanghua Healthcare Co., Ltd. Class H (3689) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$662.10M
Dividend Yield9.14%
Average Volume (3M)1.02K
Price to Earnings (P/E)2.3
Beta (1Y)>-0.01
Revenue Growth-1.48%
EPS Growth549.60%
CountryHK
Employees4,320
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.29
Shares Outstanding84,394,000
10 Day Avg. Volume720
30 Day Avg. Volume1,020
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.34
Price to Sales (P/S)0.26
P/FCF Ratio2.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Guangdong Kanghua Healthcare Co., Ltd. Class H Business Overview & Revenue Model
Company Description
Guangdong Kanghua Healthcare Co., Ltd., an investment holding company, primarily operates private hospitals in the People's Republic of China. The company operates through Hospital Services, Rehabilitation and Other Healthcare Services, Sale of Ph...
Guangdong Kanghua Healthcare Co., Ltd. Class H Financial Statement Overview
Summary
Income Statement
64
Positive
Balance Sheet
73
Positive
Cash Flow
58
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.97B | 2.06B | 2.04B | 1.85B | 1.95B |
| Gross Profit | 359.37M | 321.87M | 364.37M | 261.35M | 352.75M |
| EBITDA | 249.78M | 224.86M | 305.92M | 233.79M | 298.46M |
| Net Income | 97.01M | 15.34M | 121.06M | 59.70M | 94.31M |
Balance Sheet | |||||
| Total Assets | 2.68B | 2.74B | 2.62B | 2.72B | 2.70B |
| Cash, Cash Equivalents and Short-Term Investments | 743.33M | 678.40M | 718.52M | 754.34M | 770.34M |
| Total Debt | 326.21M | 320.66M | 426.58M | 429.92M | 494.54M |
| Total Liabilities | 1.15B | 1.28B | 1.13B | 1.22B | 1.23B |
| Stockholders Equity | 1.51B | 1.44B | 1.42B | 1.49B | 1.43B |
Cash Flow | |||||
| Free Cash Flow | 234.48M | 193.15M | 73.31M | 106.20M | 162.19M |
| Operating Cash Flow | 282.66M | 280.13M | 204.19M | 221.40M | 333.37M |
| Investing Cash Flow | -238.75M | -87.33M | -107.72M | -83.16M | -299.33M |
| Financing Cash Flow | -46.31M | -251.71M | -55.56M | -110.88M | 23.27M |
Guangdong Kanghua Healthcare Co., Ltd. Class H Technical Analysis
Negative
1.72
Price Trends
2.04
Negative
1.90
Positive
1.93
Positive
Market Momentum
<0.01
Positive
38.43
Neutral
7.70
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3689, the sentiment is Negative. The current price of 1.72 is below the 20-day moving average (MA) of 2.05, below the 50-day MA of 2.04, and below the 200-day MA of 1.93, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 38.43 is Neutral, neither overbought nor oversold. The STOCH value of 7.70 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:3689.
Guangdong Kanghua Healthcare Co., Ltd. Class H Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$376.45M | 4.98 | 4.28% | 7.10% | -2.78% | -24.77% | |
71 Outperform | HK$662.10M | 2.28 | 6.66% | 9.14% | -1.48% | 549.60% | |
56 Neutral | HK$476.77M | 15.01 | 27.04% | ― | 2.00% | ― | |
52 Neutral | HK$303.64M | 4.11 | 3.54% | 3.75% | 9.74% | 32.37% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | HK$936.00M | -275.87 | 1.85% | ― | -13.22% | -69.35% | |
45 Neutral | HK$273.34M | -2.48 | -25.22% | 3.16% | -29.10% | -343.29% |
* Healthcare Sector Average
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
1.98
0.23
13.14%
HK:9906
Honliv Healthcare Management Group Co Ltd
1.56
0.06
4.00%
HK:1419
Human Health Holdings Ltd.
0.80
0.01
1.27%
HK:1518
New Century Healthcare Holding Co. Ltd.
0.56
-0.69
-55.20%
HK:3869
Hospital Corporation of China Ltd
3.45
-2.55
-42.50%
HK:0722
UMP Healthcare Holdings Limited
0.47
0.08
20.20%
Guangdong Kanghua Healthcare Co., Ltd. Class H Corporate Events
Guangdong Kanghua Healthcare Revises Book Closure Period for 2025 AGM
Apr 28, 2026
Guangdong Kanghua Healthcare Group has announced a change to the book closure period for its register of members related to the 2025 annual general meeting. The new closure dates run from 15 June 2026 to 18 June 2026, during which no share transfe...
Guangdong Kanghua Healthcare Sets 2025 AGM, Seeks Mandate for New Share Issuance
Apr 28, 2026
Guangdong Kanghua Healthcare Group has convened its 2025 annual general meeting for 18 June 2026 in Dongguan, where shareholders will review the board and supervisory committee work reports, the 2025 financial statements and annual report, and a p...
Guangdong Kanghua Waives Loans as It Sheds Loss-Making Cardiovascular Hospital Stake
Apr 16, 2026
Guangdong Kanghua Healthcare Group has provided supplemental details on the disposal of its remaining 45% equity interest in Chongqing Kanghua Zhonglian Cardiovascular Hospital to Beijing Fazheng Industrial Group. The company disclosed that Kangxi...
Guangdong Kanghua Healthcare Delivers Strong Profit Rebound Despite Slight Revenue Dip
Mar 31, 2026
Guangdong Kanghua Healthcare Group reported a slight 1.5% decline in revenue to RMB2,024.2 million for 2025, but delivered a sharp turnaround in profitability, with profit surging more than eightfold to RMB94.5 million. Earnings attributable to sh...
Guangdong Kanghua Healthcare Proposes RMB0.16 Final Dividend for 2025
Mar 31, 2026
Guangdong Kanghua Healthcare Group Co., Ltd. has proposed a final ordinary cash dividend of RMB 0.16 per share for the financial year ended 31 December 2025, with shareholder approval scheduled for 18 June 2026. The dividend, subject to confirmati...
Guangdong Kanghua Sells Remaining Stake in Underperforming Kangxin Hospital
Mar 23, 2026
Guangdong Kanghua Healthcare Group has agreed to sell its remaining 45% equity stake in Chongqing-based Kangxin Hospital to Beijing Fazheng Industrial Group for an estimated RMB14.2 million. After completion, Kangxin Hospital will no longer be acc...
Guangdong Kanghua Healthcare Sets March 2026 Board Meeting to Approve 2025 Results
Mar 19, 2026
Guangdong Kanghua Healthcare Group has scheduled a board meeting for 31 March 2026 to review and approve the annual results of the company and its subsidiaries for the financial year ended 31 December 2025. The board will also consider the publica...
Guangdong Kanghua Healthcare Shareholders Approve 2026 Hospital Lease at EGM
Mar 3, 2026
Guangdong Kanghua Healthcare Group Co., Ltd., a Hong Kong-listed hospital operator in Guangdong Province, maintains a dual-share structure comprising domestic and H shares, with the Wang family and its affiliated entities collectively holding a do...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.